Investigating the relationship between physical activity and side effects associated with systemic anti-cancer therapies

A feasibility study investigating the relationship between physical activity and side effects associated with systemic anti-cancer therapies

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16575002

Enrollment

Registered

2026-02-05

Start date

2026-02-15

Completion date

Unknown

Last updated

2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related functional decline and reduced physical activity in adults receiving systemic anti-cancer therapy Cancer

Interventions

Participants will be identified through routine oncology clinics and screened for eligibility prior to commencing first-line systemic anti-cancer therapy (SACT). Following informed consent and baselin

no randomisation methods are used.

Eligibility

Sex/Gender

All

Age

16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged =16 years 2. Diagnosis of breast, lung, colorectal or prostate cancer 3. Planned to commence first-line systemic anti-cancer therapy (SACT) 4. Able to provide written informed consent 5. ECOG performance status 0–1 6. Able to participate in a physical activity-based intervention

Exclusion criteria

Exclusion criteria: 1. Contraindications to exercise or physical activity, as identified by clinical assessment 2. Unstable or uncontrolled comorbidities that would preclude safe participation 3. Cognitive impairment or other factors preventing informed consent 4. Already participating in a structured prehabilitation or exercise programme

Countries

England, United Kingdom

Contacts

Public ContactBen Hood

ben.hood@nhs.net+44 01912139217

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026